{
  "id": 14787441,
  "title": "Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors",
  "url": "https://urgent.news/2026/10/15/conexeu-sciences-announces-5-million-private-placement-led-by",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-15T20:36:35.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/conexeu-sciences-announces-5-million-private-placement-led-by-existing-shareholders-management-and-directors"
  },
  "original_language": "en",
  "account": null,
  "summary": "Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first quarter of 2027 RENO, Nev., Oct. 15, 2026 (GLOBE NEWSWIRE) — Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage medical device and regenerative…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Atico Announces Closing of US$16.4 Million Convertible Debenture Private Placement and Settles Legacy Liabilities",
        "url": "https://urgent.news/2026/10/15/atico-announces-closing-of-us-16-4-million-convertible-debenture",
        "published": "2026-10-15T20:35:46.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}